The only safe assumption to make about today’s current gold standard imaging modality used to identify and evaluate atheromatous plaque in the peripheral arteries is that there is not one gold standard. To locate and evaluate these plaques that cause peripheral vascular disease (PVD), physicians have multiple tried-and-true imaging tests at their disposal.
Safe delivery of the balloon or stent through fragile vasculature during percutaneous transluminal coronary angioplasty (PTCA) procedures is an important criterion for successful patient outcomes.
July 10, 2008 - Boston Scientific Corp. this week launched its Atlantis .018 Peripheral Imaging Catheter, which reportedly brings existing 40 MHz coronary standard ultrasound imaging resolution to peripheral interventions. The company said the product is available for immediately release in the U.S.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Cardiology fellows are expanding their knowledge in cardiovascular imaging. Not only do virtually all cardiology fellows get Level 2 training in echocardiography and many in nuclear cardiology but now, an increasing number of fellows are training in cardiac MR and cardiac CT.
What makes cardiologists more capable of reading cardiac imaging exams than other physicians such as radiologists, who ...
July 10, 2008 - Datascope Corp. said today it exercised its option to acquire the Peripheral Vascular Stent business of ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
(Editor's note: this article was updated in March 2017 with links at the bottom to more current stent technology ...
July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has ...
Physicians recognize the importance of ventricular assist devices (VADs) every time a congestive heart failure (CHF) ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
InTouch Technologies Inc. offers StrokeRESPOND to extend the functionality of its telemedicine, Remote Presence robotic ...
Thoratec Corp. received FDA approval of its PMA (premarket approval) application, allowing the use of its HeartMate II LVAS (left ventricular assist system) as a bridge-to-transplantation (BTT) in patients suffering from advanced-stage heart failure.
Northeast Monitoring’s DR200/HE is a combination 14-day Holter plus 30-day Event recorder integrated into a single unit ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 9, 2008 – The Medical Imaging & Technology Alliance (MITA) today applauded the U.S. Congress for passing Medicare ...
The FDA cleared GE Healthcare’s new LightSpeed CT750 HD, said to be the world’s first high-definition CT scanner that ...
Vascular Insights received 510(k) clearance from the FDA to market its ClariVein infusion catheter for infusion of physician-specified agents in the peripheral vasculature. ClariVein is a percutaneous, 2 2/3 Fr (0.035-inch) catheter, containing a rotating wire driven by a motor, that enhances fluid dispersion in the treatment area.
July 09, 2008
